Clinical Trial Update: Multi-modal Neuroimaging in Alzheimer's Disease IMAP+ [NA]

View source ↗

Summary

A completed clinical trial examining multi-modal neuroimaging in Alzheimer's disease (IMAP+) conducted by University Hospital in Caen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: University Hospital, Caen | Conditions: Alzheimer's Disease | NA | Status: COMPLETED